FutureHouse and Google DeepMind AI agents reportedly reach Nature with drug-discovery work
The claim points to a higher bar for lab agents, but the cited post omits the papers, candidates, and human-supervision details.
By Ryan Merket · Published
Primary source: Aligned News
Why it matters
AI agents are moving from demo workflows into claims of original scientific contribution, but founders and investors should separate peer-reviewed validation from unverified autonomy claims.
FutureHouse and Google DeepMind have become the latest AI labs to push lab-agent claims into peer review: Aligned News reports that FutureHouse Robin and Google DeepMind Co-Scientist were both published in Nature after autonomously identifying novel drug candidates researchers had missed.